328567-13-1Relevant academic research and scientific papers
COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER STEM CELLS
-
Page/Page column 52, (2013/03/28)
The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof: Formula (I).
Identification of a selective small molecule inhibitor of breast cancer stem cells
Germain, Andrew R.,Carmody, Leigh C.,Morgan, Barbara,Fernandez, Cristina,Forbeck, Erin,Lewis, Timothy A.,Nag, Partha P.,Ting, Amal,Verplank, Lynn,Feng, Yuxiong,Perez, Jose R.,Dandapani, Sivaraman,Palmer, Michelle,Lander, Eric S.,Gupta, Piyush B.,Schreiber, Stuart L.,Munoz, Benito
scheme or table, p. 3571 - 3574 (2012/07/03)
A high-throughput screen (HTS) with the National Institute of Health-Molecular Libraries Small Molecule Repository (NIH-MLSMR) compound collection identified a class of acyl hydrazones to be selectively lethal to breast cancer stem cell (CSC) enriched pop
